During the last session, FibroBiologics Inc (NASDAQ:FBLG)’s traded shares were 0.35 million, with the beta value of the company hitting -0.97. At the end of the trading day, the stock’s price was $1.19, reflecting an intraday gain of 9.17% or $0.1. The 52-week high for the FBLG share is $13.59, that puts it down -1042.02 from that peak though still a striking 36.13% gain since the share price plummeted to a 52-week low of $0.76. The company’s market capitalization is $44.91M, and the average intraday trading volume over the past 10 days was 0.26 million shares, and the average trade volume was 306.67K shares over the past three months.
FibroBiologics Inc (NASDAQ:FBLG) trade information
FibroBiologics Inc (FBLG) registered a 9.17% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 9.17% in intraday trading to $1.19, hitting a weekly high. The stock’s 5-day price performance is 46.41%, and it has moved by 16.67% in 30 days. Based on these gigs, the overall price performance for the year is -89.17%. The short interest in FibroBiologics Inc (NASDAQ:FBLG) is 2.25 million shares and it means that shorts have 15.2 day(s) to cover.
The consensus price target of analysts on Wall Street is $9, which implies an increase of 86.78% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9 and $9 respectively. As a result, FBLG is trading at a discount of -656.3% off the target high and -656.3% off the low.
FBLG Dividends
FibroBiologics Inc is due to release its next quarterly earnings on 2025-Mar-30. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
FibroBiologics Inc (NASDAQ:FBLG)’s Major holders
FibroBiologics Inc insiders own 21.64% of total outstanding shares while institutional holders control 15.90%, with the float percentage being 20.29%. FUND EVALUATION GROUP, LLC is the largest shareholder of the company, while 85.0 institutions own stock in it. As of 2024-06-30, the company held over 1.06 million shares (or 3.2247% of all shares), a total value of $5.26 million in shares.
The next largest institutional holding, with 0.92 million shares, is of BLACKROCK INC.’s that is approximately 2.8086% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $4.59 million.
Also, the Mutual Funds coming in first place with the largest holdings of FibroBiologics Inc (FBLG) shares are iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . Data provided on Mar 31, 2025 indicates that iShares Trust-iShares Russell 2000 ETF owns about 639.9 shares. This amounts to just over 1.70 percent of the company’s overall shares, with a $0.76 million market value. The same data shows that the other fund manager holds slightly less at 407.67, or about 1.08% of the stock, which is worth about $0.49 million.
